Autobio(SH:603658) Sou Hu Cai Jing·2025-08-11 11:38Core Viewpoint - Antu Biology's stock closed at 42.34 yuan, up 3.39%, with a rolling PE ratio of 21.22, marking a new low in 88 days, and a total market capitalization of 24.194 billion yuan [1] Company Summary - Antu Biology specializes in the research, manufacturing, integration, and service of in vitro diagnostic reagents and instruments, with key products including immunodiagnostic reagents, microbiological testing reagents, molecular diagnostic reagents, biochemical reagents, and instruments [1] - As of March 31, 2025, the number of shareholders reached 34,163, an increase of 3,382 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] - The latest quarterly report for Q1 2025 shows revenue of 996 million yuan, a year-on-year decrease of 8.56%, and a net profit of 270 million yuan, down 16.76%, with a gross profit margin of 65.07% [1] Industry Summary - The average PE ratio for the medical device industry is 56.56, with a median of 39.76, placing Antu Biology at 45th in the industry ranking [1] - The industry average market capitalization is 118.97 billion yuan, while the median is 57.67 billion yuan [2]